Canada’s chief public health officer Dr. Theresa Tam said Sunday the rapid test developed by Ottawa-based biotech company Spartan Bioscience for COVID-19 “did not perform well” in a clinical setting, despite earlier results which appeared promising, adding the failures were believed to be related to the test’s proprietary swab.
Canada
Coronavirus outbreak: Tam says Spartan rapid test for COVID-19 ‘didn’t perform well’ in clinical setting
More Videos
-
Former CSIS exec on bombshell RCMP arrest of suspected hitmen in Nijjar case
-
More foreign interference actions coming after inquiry report, India arrests: LeBlanc
-
United Kingdom bans easy to guess passwords in cyber-attack crackdown
-
Loblaw boycott: Small grocers, co-ops seeing boost
-
Cancelled carbon capture project casts doubt on Canada’s climate plan
-
Is the government of India behind a global campaign against Sikh separatism?
You are viewing an Accelerated Mobile Webpage.
View Original Article